MIT Professional Education is excited to introduce a new Professional Certificate Program in Biomanufacturing. Building on the existing research and innovation taking place on the MIT campus and in Boston's biotechnology community, this certificate program aims to provide professionals in biomanufacturing, biotechnology and pharmaceutical fields the opportunity to bring a more holistic approach to new and existing technologies back to their companies.
Dr. Pin-Kuang Lai is an assistant professor in the department of chemical engineering and materials science at Stevens Institute of Technology
Ryan Holcomb
Dr. Ryan E. Holcomb is employed as a Principal Scientist for Legacy BioDesign LLC, a contract research organization specializing in the formulation of therapeutic proteins and peptides.
Brent Kendrick
Brent Kendrick is founder and owner of First Principles Biopharma, LLC, specializing in biopharmaceutical data sciences, data analysis automation, and consulting in formulation/analytical development/product characterization.
Michael Jewett
Michael Jewett is the Charles Deering McCormick Professor of Teaching Excellence, the Walter P. Murphy Professor of Chemical and Biological Engineering, and Director of the Center for Synthetic Biology at Northwestern University. Dr. Jewett received his PhD in 2005 at Stanford University, completed postdoctoral studies at the Center for Microbial Biotechnology in Denmark and the Harvard Medical School, and was a guest professor at the Swiss Federal Institute of Technology (ETH Zurich). He is the recipient of the NIH Pathway to Independence Award, David and Lucile Packard Fellowship in Science and Engineering, Camille-Dreyfus Teacher-Scholar Award, and a Finalist for the Blavatnik National Awards for Young Scientists, among others. He is the co-founder of SwiftScale Biologics, Stemloop, Inc., Pearl Bio, Induro Therapeutics, and Design Pharmaceuticals. Jewett is a Fellow of AIMBE, AAAS, and NAI.
Bazarragchaa Damdinsuren
Bazarragchaa Damdinsuren, MD, PhD is a product quality team leader at Office of Biotechnology Products (OBP), Office of Pharmaceutical Quality at CDER, FDA. Dr. Damdinsuren received his MD from National Medical University in Mongolia and his PhD from Osaka University in Japan, and completed postdoc in immunology and cell biology at the National Institutes of Health (NIH). He joined the OBP/FDA as a Commissioner’s Fellow in 2010.
Dr. Seongkyu Yoon is a Professor in the Department of Chemical Engineering and the Ward Endowed Professor in Biomedical Sciences at UMass Lowell. He is also the UMass Site Director of the Advanced Mammalian Biomanufacturing Innovation Center and a contributor to the National Biomanufacturing Innovation Institute. Dr. Yoon runs a systems biology group that conducts research on systems biotechnology, life science informatics, bioprocess data analytics, and regulatory sciences with the objective of developing innovative biomanufacturing platforms for protein/cell/gene biotherapeutics.
Dr. Richard D. Braatz is the Edwin R. Gilliland Professor of Chemical Engineering at MIT, where he conducts research into advanced biopharmaceutical manufacturing systems. In this role, he leads process data analytics, mechanistic modeling, and control systems for several projects on campus, including those focused on monoclonal antibody, viral vaccine, and gene therapy manufacturing.
Get more from your bioprocess data. In this intensive, four-day course, designed specifically for scientists and engineers in the biopharma industry, you’ll explore best practices for translating biopharmaceutical manufacturing data into reliable models and better decisions. Working with academic and industry experts, you’ll acquire strategies for improving manufacturing accuracy, enhancing regulatory efficiency, and refining bioprocess operations.
Derrick Katayama
Derrick Katayama, Ph.D. is the Principal Scientist at Legacy BioDesign, LLC. Dr. Katayama received his Ph.D. in Pharmaceutical Sciences from the University of Colorado Health Sciences Center (UCHSC) with studies focused on understanding protein stability in both liquid and lyophilized forms. Dr. Katayama has worked in the biopharmaceutical industry for over 10 years, prior to joining Legacy BioDesign, LLC.